Skip to main content
. 2004 Jan 26;2004(1):CD003133. doi: 10.1002/14651858.CD003133.pub2

3.13. Analysis.

Comparison 3 Leukotriene Receptor Antagonists (LTRA) + ICS vs. ICS (TAPERING protocol) in WELL CONTROLLED patients, Outcome 13 Change in serum eosinophils at lowest tolerated dose (at 6‐ 24 weeks).